These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 7311945)

  • 1. [Clinical study of a new bronchodilator molecule in pediatrics (Th 1165, Fenoterol-Berotec)].
    Longo L; Patruno D; Tempesta A; Scaramuzzi O; Laudadio L
    Minerva Pediatr; 1981 Aug; 33(16):831-4. PubMed ID: 7311945
    [No Abstract]   [Full Text] [Related]  

  • 2. [Bronchospasmolytic and extrabronchial action of Berotec (Fenoterol, Th 1165) in patients with asthma or chronic bronchitis with bronchial spasm].
    Rozniecki J; Grabski W
    Pol Tyg Lek; 1975 Feb; 30(7):301-4. PubMed ID: 1118349
    [No Abstract]   [Full Text] [Related]  

  • 3. A trial of fenoterol for nocturnal bronchospasm.
    McIntosh D
    Practitioner; 1983 Nov; 227(1385):1757-64. PubMed ID: 6657582
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative evaluation of the bronchospasmolytic action of fenoterol and trimethoquinol].
    Tranfa CM; Illiano A; Donato Di Paola RM; Giacomelli P; Marsico SA
    Arch Monaldi; 1980; 35(5-6):273-80. PubMed ID: 7344647
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of the protective action of Salbutamol Polfa--aerosol in relation to histamine induced bronchospasm in patients with bronchial asthma, in comparison with the effect of Ventolin-Pliva, Astmopent-Polfa and Berotec-Boehringer.
    Rozniecki J; Szmidt M; Grabski W; Gondorowicz K
    Mater Med Pol; 1977; 9(4):331-5. PubMed ID: 599965
    [No Abstract]   [Full Text] [Related]  

  • 6. [Berotek treatment of bronchial asthma in combination with ischemic heart disease].
    Klusova EV; Semenovich NI; Polivanov EG; Pashkova TL
    Sov Med; 1979 Apr; (4):48-51. PubMed ID: 375421
    [No Abstract]   [Full Text] [Related]  

  • 7. [Th 1165a (Berotec) in the prevention of bronchospasm induced with pneumoallergens].
    Melillo G; Cocco G; D'Amato G; Sales L; Di Ruggiero G
    Arch Monaldi; 1975; 30(5-6):390-401. PubMed ID: 12727
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fenoterol in the diagnosis and treatment of reversible bronchospasm].
    Sevieri GP; Quartieri F; Del Bono N
    Clin Ter; 1981 Dec; 99(6):615-22. PubMed ID: 7333073
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with the inhalation of Berotec powder in the treatment of asthma in children.
    Bach-Mortensen N
    Eur J Respir Dis Suppl; 1983; 130():25-7. PubMed ID: 6581058
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bronchodilating and antiallergic effects of fenoterol in antigen-induced bronchial obstruction. Comparison between metered aerosol and respirator solution (author's transl)].
    Schultze-Werninghaus G; Gonsior E; Meier-Sydow J
    Prax Klin Pneumol; 1978 Apr; 32(4):257-65. PubMed ID: 643798
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of bronchodilator and extrabronchial action of salbutamol Polfa-aerosol in comparison with Ventolin Pliva, Berotec Boehringer Ingelheim and Astmopent Polfa in patients with chronic obstructive bronchitis.
    Roźniecki J; Gondorowicz K; Szmidt M; Grabski W
    Mater Med Pol; 1978; 10(2):139-45. PubMed ID: 703389
    [No Abstract]   [Full Text] [Related]  

  • 12. Assessment of the efficacy of two new bronchodilators (salbutamol and fenoterol) in children.
    Baran D; Yernault JC; Azama M; Englert M
    Acta Paediatr Belg; 1977; 30(2):105-8. PubMed ID: 888690
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of the bronchodilating effect of TH 1165 A and of salbutamol in patients with spastic obstructive ventilatory syndrome].
    Iaia E; Cagnazzo R; Digilio VS; Scoditti A
    Clin Ter; 1981 Dec; 99(5):499-505. PubMed ID: 7333071
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical experiences with a new beta 2-receptor stimulant in spastic lung diseases in pediatrics].
    Starnegg Q
    Wien Med Wochenschr; 1971 May; 121(22):455-7. PubMed ID: 5092121
    [No Abstract]   [Full Text] [Related]  

  • 15. [Postoperative respiratory therapy: bronchospasmolytic activity and side-effects of some recently introduced beta-sympatheticomimetic agents (author's transl)].
    Brandl M; Beer S; Hamer P
    Anasth Intensivther Notfallmed; 1981 Aug; 16(4):197-202. PubMed ID: 7027819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in static and dynamic pulmonary volumes in patients with bronchial asthma treated with a new bronchodilator agent: Th 1165 a].
    Maiorano V; D'Angelo R; Frisotti A; Carnimeo N
    Torace; 1976 Jan; 18(1-2):20-39. PubMed ID: 996854
    [No Abstract]   [Full Text] [Related]  

  • 17. [Possibility of prevention of histamine-induced bronchospastic reaction with fenoterol, ipratropium bromide and lidocaine in patients with chronic bronchitis].
    Kurgan J
    Pol Tyg Lek; 1985 Feb; 40(5):131-4. PubMed ID: 3157103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study of the bronchodilating effect of SCH 1000, berotec and of the association of the two drugs in patients with spastic bronchitis (author's transl)].
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1974; 65(5):534-9. PubMed ID: 4282820
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventive effect of fenoterol on allergen-induced bronchospasm.
    D'Amato G; Schiano M; Balzano G; Cocco G; Melillo G
    Eur J Respir Dis Suppl; 1983; 128 (Pt 2)():509-12. PubMed ID: 6352311
    [No Abstract]   [Full Text] [Related]  

  • 20. [Multicenter clinical study on the delayed use of ipratropium-fenoterol in broncho-obstructive pathology].
    Babich S; Bariffi F; Bisetti A; Carnimeo N; Cavalli A; Corda M; De Michele G; Girbino G; Mancini PA; Melica A
    Arch Monaldi; 1983; 38(5-6):305-16. PubMed ID: 6238585
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.